Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
This study is currently recruiting participants.
Verified December 2012 by Massachusetts General Hospital
Sponsor:
Massachusetts General Hospital
Collaborator:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Yi-Bin A. Chen, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01398501
First received: July 19, 2011
Last updated: December 16, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2016 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |